Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

340 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Targeted-release budesonide versus placebo in patients with IgA nephropathy (NEFIGAN): a double-blind, randomised, placebo-controlled phase 2b trial.
Fellström BC, Barratt J, Cook H, Coppo R, Feehally J, de Fijter JW, Floege J, Hetzel G, Jardine AG, Locatelli F, Maes BD, Mercer A, Ortiz F, Praga M, Sørensen SS, Tesar V, Del Vecchio L; NEFIGAN Trial Investigators. Fellström BC, et al. Among authors: feehally j. Lancet. 2017 May 27;389(10084):2117-2127. doi: 10.1016/S0140-6736(17)30550-0. Epub 2017 Mar 28. Lancet. 2017. PMID: 28363480 Clinical Trial.
IgA nephropathy: recent developments.
Floege J, Feehally J. Floege J, et al. Among authors: feehally j. J Am Soc Nephrol. 2000 Dec;11(12):2395-2403. doi: 10.1681/ASN.V11122395. J Am Soc Nephrol. 2000. PMID: 11095664 Review. No abstract available.
Pathogenesis of IgA nephropathy.
Barratt J, Feehally J, Smith AC. Barratt J, et al. Among authors: feehally j. Semin Nephrol. 2004 May;24(3):197-217. doi: 10.1016/j.semnephrol.2004.01.002. Semin Nephrol. 2004. PMID: 15156526 Review.
IgA nephropathy.
Barratt J, Feehally J. Barratt J, et al. Among authors: feehally j. J Am Soc Nephrol. 2005 Jul;16(7):2088-97. doi: 10.1681/ASN.2005020134. Epub 2005 Jun 1. J Am Soc Nephrol. 2005. PMID: 15930092 Review. No abstract available.
IgA nephropathy: introduction.
Feehally J, Barratt J. Feehally J, et al. Semin Nephrol. 2008 Jan;28(1):1-3. doi: 10.1016/j.semnephrol.2007.10.002. Semin Nephrol. 2008. PMID: 18222340 No abstract available.
IgA nephropathy at two score and one.
Coppo R, Feehally J, Glassock RJ. Coppo R, et al. Among authors: feehally j. Kidney Int. 2010 Feb;77(3):181-6. doi: 10.1038/ki.2009.427. Epub 2009 Nov 18. Kidney Int. 2010. PMID: 19924103 Free article.
An update on the pathogenesis and treatment of IgA nephropathy.
Boyd JK, Cheung CK, Molyneux K, Feehally J, Barratt J. Boyd JK, et al. Among authors: feehally j. Kidney Int. 2012 May;81(9):833-43. doi: 10.1038/ki.2011.501. Epub 2012 Feb 8. Kidney Int. 2012. PMID: 22318424 Free article. Review.
Validation of the Oxford classification of IgA nephropathy in cohorts with different presentations and treatments.
Coppo R, Troyanov S, Bellur S, Cattran D, Cook HT, Feehally J, Roberts IS, Morando L, Camilla R, Tesar V, Lunberg S, Gesualdo L, Emma F, Rollino C, Amore A, Praga M, Feriozzi S, Segoloni G, Pani A, Cancarini G, Durlik M, Moggia E, Mazzucco G, Giannakakis C, Honsova E, Sundelin BB, Di Palma AM, Ferrario F, Gutierrez E, Asunis AM, Barratt J, Tardanico R, Perkowska-Ptasinska A; VALIGA study of the ERA-EDTA Immunonephrology Working Group. Coppo R, et al. Among authors: feehally j. Kidney Int. 2014 Oct;86(4):828-36. doi: 10.1038/ki.2014.63. Epub 2014 Apr 2. Kidney Int. 2014. PMID: 24694989 Free PMC article.
340 results